SABA MADHOUN: Open Payments
NPI 1871958744 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 6 companies in 2025. Trend: 2023 $513 · 2024 $510 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $183 |
| Actelion Pharmaceuticals US, Inc. | 4 | $75 |
| Abbott Laboratories | 2 | $42 |
| Daxor Corporation | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: JARDIANCE, OPSUMIT, BVA-100, CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ELIQUIS, LOKELMA, OPSYNVI.
Industry payments across MI — which companies pay providers there.
